GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $38.10 $43.42 Thursday, 18th Apr 2024 CLDX stock ended at $38.53. This is 2.78% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.89% from a day low at $38.31 to a day high of $39.80.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
2020-09-18 $12.11 $13.12 $12.11 $12.94 1 322 066
2020-09-17 $11.67 $12.58 $11.52 $12.11 479 772
2020-09-16 $11.84 $12.25 $11.64 $11.72 382 211
2020-09-15 $12.67 $13.00 $11.56 $11.73 562 058
2020-09-14 $12.28 $13.43 $12.26 $12.66 861 005
2020-09-11 $11.72 $12.25 $11.72 $12.01 311 957
2020-09-10 $11.97 $12.49 $11.70 $11.71 494 400
2020-09-09 $11.44 $12.17 $11.44 $11.99 954 379
2020-09-08 $10.51 $11.60 $10.46 $11.26 626 446
2020-09-04 $11.03 $11.39 $10.26 $10.68 796 856
2020-09-03 $12.36 $12.50 $10.97 $11.37 819 303
2020-09-02 $11.96 $12.82 $11.82 $12.47 831 512
2020-09-01 $11.84 $12.10 $11.35 $11.88 405 208
2020-08-31 $12.06 $12.12 $11.38 $11.94 438 111
2020-08-28 $11.07 $12.16 $10.88 $12.00 560 016
2020-08-27 $11.30 $11.36 $10.92 $11.11 695 943
2020-08-26 $11.40 $11.84 $11.15 $11.29 291 528
2020-08-25 $11.11 $11.46 $10.93 $11.44 384 740
2020-08-24 $11.09 $11.46 $10.71 $11.11 822 411
2020-08-21 $11.36 $11.49 $10.68 $10.99 523 617
2020-08-20 $11.46 $11.65 $11.23 $11.50 418 615
2020-08-19 $11.46 $11.80 $11.11 $11.61 559 411
2020-08-18 $10.94 $11.98 $10.61 $11.49 733 376
2020-08-17 $10.26 $11.20 $10.25 $10.94 773 253
2020-08-14 $10.28 $10.38 $9.66 $10.31 532 486
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT